The ViraPower™ Adenoviral Promoterless Gateway™ Expression Kit combines Invitrogen’s ViraPower™ Adenoviral and Gateway™ technologies to facilitate easy recombination-based cloning and adenoviral-based, transient expression of a target gene in dividing and non-dividing mammalian cells. The pAd⁄PL-DEST™ vector allows generation of an adenovirus containing the target gene where expression is driven by a promoter of choice. Alternatively, the vector may also be used to express small RNA molecules from their appropriate promoters.

Advantages
• High efficiency and rapid recombination cloning
• Produces high titer adenoviral stocks
• Efficient delivery of the gene to dividing and non-dividing mammalian cells in vitro or in vivo
• Allows gene of interest to be controlled by a promoter of choice
• Produces replication-incompetent virus for enhanced biosafety of the system
• Amenable for use in high-throughput applications

Key Features
• Gateway™ Technology for efficient and rapid cloning
• Promoterless vector that allows gene of interest to be controlled by a promoter of choice
• Human Ad5 sequences (ΔE3) and Viral Inverted Terminal Repeats (ITRs) for packaging of the expression construct into virions
• Ampicillin selection marker

Kit includes
• pAd⁄PL-DEST™ Gateway™ Vector (6 μg. Cat. No. V493-20)
• 293A Cell Line (3 x 10⁶ cells, frozen. Cat. No. R705-07)

For research use only. Not intended for any therapeutic or diagnostic use.